Search research articles
Contact Us
Filters
Showing results (61-70 of 77) with videos related to
Page
of 8
Sort By:
Molecular Cancer Research : MCR
|
April 27, 2025
Exploring STEAP1 Expression in Prostate Cancer Cells in Response to Androgen Deprivation and in Small Extracellular Vesicles
Candice L Bizzaro, Camila A Bach, Ricardo A Santos, et al.
Biorxiv : the Preprint Server for Biology
|
April 3, 2026
Suppression of de novo lipogenesis and dietary PUFA supplementation inhibit prostate cancer progression
Silvia D Rodrigues, Caroline Fidalgo Ribeiro, Giuseppe N Fanelli, et al.
Biorxiv : the Preprint Server for Biology
|
August 13, 2025
Reversible therapeutic resistance in <i>EGFR</i> mutant lung cancer caused by <i>RB1</i> loss induced lineage plasticity
Letian Zhang, Meenalakshmi Chinnam, Bradley Balk, et al.
The Journal of Clinical Investigation
|
July 18, 2024
Notch signaling suppresses neuroendocrine differentiation and alters the immune microenvironment in advanced prostate cancer
Sheng-Yu Ku, Yanqing Wang, Maria Mica Garcia, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
April 1, 2025
An Agrin-YAP/TAZ Rigidity Sensing Module Drives EGFR-Addicted Lung Tumorigenesis
Reza Bayat Mokhtari, Divyaleka Sampath, Paige Eversole, et al.
Scientific Reports
|
November 7, 2022
The NOGO receptor NgR2, a novel αVβ3 integrin effector, induces neuroendocrine differentiation in prostate cancer
Fabio Quaglia, Shiv Ram Krishn, Khalid Sossey-Alaoui, et al.
Biorxiv : the Preprint Server for Biology
|
June 3, 2025
Increasing Stemness Drives Prostate Cancer Progression, Plasticity, Therapy Resistance and Poor Patient Survival
Xiaozhuo Liu, Eduardo Cortes, Yibing Ji, et al.
Science (New York, N.Y.)
|
January 7, 2017
SOX2 promotes lineage plasticity and antiandrogen resistance in TP53- and RB1-deficient prostate cancer
Ping Mu, Zeda Zhang, Matteo Benelli, et al.
Nature Reviews. Cancer
|
June 3, 2025
Acquired resistance in cancer: towards targeted therapeutic strategies
Alice Soragni, Erik S Knudsen, Thomas N O'Connor, et al.
Nature Communications
|
November 20, 2024
Increased translation driven by non-canonical EZH2 creates a synthetic vulnerability in enzalutamide-resistant prostate cancer
Shankha S Chatterjee, Juan F Linares, Tania Cid-Diaz, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 77) with videos related to
Sort By:
Page
of 8
Molecular Cancer Research : MCR
|
April 27, 2025
Exploring STEAP1 Expression in Prostate Cancer Cells in Response to Androgen Deprivation and in Small Extracellular Vesicles
Candice L Bizzaro, Camila A Bach, Ricardo A Santos, et al.
Biorxiv : the Preprint Server for Biology
|
April 3, 2026
Suppression of de novo lipogenesis and dietary PUFA supplementation inhibit prostate cancer progression
Silvia D Rodrigues, Caroline Fidalgo Ribeiro, Giuseppe N Fanelli, et al.
Biorxiv : the Preprint Server for Biology
|
August 13, 2025
Reversible therapeutic resistance in <i>EGFR</i> mutant lung cancer caused by <i>RB1</i> loss induced lineage plasticity
Letian Zhang, Meenalakshmi Chinnam, Bradley Balk, et al.
The Journal of Clinical Investigation
|
July 18, 2024
Notch signaling suppresses neuroendocrine differentiation and alters the immune microenvironment in advanced prostate cancer
Sheng-Yu Ku, Yanqing Wang, Maria Mica Garcia, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
April 1, 2025
An Agrin-YAP/TAZ Rigidity Sensing Module Drives EGFR-Addicted Lung Tumorigenesis
Reza Bayat Mokhtari, Divyaleka Sampath, Paige Eversole, et al.
Scientific Reports
|
November 7, 2022
The NOGO receptor NgR2, a novel αVβ3 integrin effector, induces neuroendocrine differentiation in prostate cancer
Fabio Quaglia, Shiv Ram Krishn, Khalid Sossey-Alaoui, et al.
Biorxiv : the Preprint Server for Biology
|
June 3, 2025
Increasing Stemness Drives Prostate Cancer Progression, Plasticity, Therapy Resistance and Poor Patient Survival
Xiaozhuo Liu, Eduardo Cortes, Yibing Ji, et al.
Science (New York, N.Y.)
|
January 7, 2017
SOX2 promotes lineage plasticity and antiandrogen resistance in TP53- and RB1-deficient prostate cancer
Ping Mu, Zeda Zhang, Matteo Benelli, et al.
Nature Reviews. Cancer
|
June 3, 2025
Acquired resistance in cancer: towards targeted therapeutic strategies
Alice Soragni, Erik S Knudsen, Thomas N O'Connor, et al.
Nature Communications
|
November 20, 2024
Increased translation driven by non-canonical EZH2 creates a synthetic vulnerability in enzalutamide-resistant prostate cancer
Shankha S Chatterjee, Juan F Linares, Tania Cid-Diaz, et al.
Page
of 8